Cerenome, Inc. (CNSY)
2.25
-0.08
(-3.23%)
USD |
NASDAQ |
Sep 14, 10:28
Cerenome Price : 2.25 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 2.40 | 2.49 | 2.31 | 2.325 | 79989.00 |
| Sep 10, 2026 | 2.47 | 2.64 | 2.36 | 2.39 | 102037.0 |
| Sep 09, 2026 | 2.66 | 2.760 | 2.489 | 2.49 | 82620.00 |
| Sep 08, 2026 | 2.74 | 2.76 | 2.60 | 2.70 | 48714.00 |
| Sep 04, 2026 | 2.89 | 3.00 | 2.74 | 2.755 | 35291.00 |
| Sep 03, 2026 | 2.96 | 3.05 | 2.86 | 2.98 | 42412.00 |
| Sep 02, 2026 | 2.74 | 2.94 | 2.74 | 2.94 | 61113.00 |
| Sep 01, 2026 | 2.79 | 2.800 | 2.619 | 2.71 | 71375.00 |
| Aug 31, 2026 | 3.01 | 3.09 | 2.80 | 2.82 | 117545.0 |
| Aug 28, 2026 | 3.13 | 3.19 | 3.00 | 3.05 | 35196.00 |
| Aug 27, 2026 | 2.99 | 3.25 | 2.99 | 3.10 | 69368.00 |
| Aug 26, 2026 | 3.03 | 3.063 | 3.00 | 3.02 | 18059.00 |
| Aug 25, 2026 | 2.94 | 3.121 | 2.94 | 3.085 | 29629.00 |
| Aug 24, 2026 | 3.08 | 3.110 | 2.92 | 2.96 | 44559.00 |
| Aug 21, 2026 | 3.04 | 3.115 | 2.97 | 3.07 | 106240.0 |
| Aug 20, 2026 | 3.18 | 3.20 | 3.00 | 3.00 | 54467.00 |
| Aug 19, 2026 | 3.06 | 3.19 | 3.01 | 3.19 | 51425.00 |
| Aug 18, 2026 | 3.20 | 3.20 | 3.07 | 3.08 | 92587.00 |
| Aug 17, 2026 | 3.43 | 3.50 | 3.00 | 3.20 | 272033.0 |
| Aug 14, 2026 | 3.55 | 3.82 | 3.52 | 3.68 | 109031.0 |
| Aug 13, 2026 | 3.75 | 3.92 | 3.64 | 3.70 | 62111.00 |
| Aug 12, 2026 | 3.80 | 3.96 | 3.70 | 3.70 | 65901.00 |
| Aug 11, 2026 | 3.79 | 3.85 | 3.65 | 3.83 | 62769.00 |
| Aug 10, 2026 | 3.80 | 4.03 | 3.80 | 3.84 | 46937.00 |
| Aug 07, 2026 | 3.78 | 3.955 | 3.77 | 3.83 | 68298.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ernexa Therapeutics, Inc. | 4.30 |
| ACADIA Pharmaceuticals, Inc. | 27.57 |
| Alnylam Pharmaceuticals, Inc. | 245.63 |
| Anika Therapeutics, Inc. | 20.86 |
| Savara, Inc. | 5.32 |
Price Related Metrics
| PS Ratio | 3.130 |
| Price to Book Value | 3.011 |
| Earnings Yield | -196.0% |
| Market Cap | 16.45M |